Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07297797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 2026 → Dec 2026
See other at-risk trials from Fujian Shengdi Pharmaceutical Co., Ltd.

Record History

  1. Enrollment closed, study ongoing Primary completion pushed from Jul 2026 to Dec 2026 · Enrollment target: estimated 234 to confirmed 238 · Secondary endpoints: 11 to 7 · 1 morev3 Show 4 more changesShow less
    • Primary completion pushed from Jul 2026 to Dec 2026
    • Enrollment target: estimated 234 to confirmed 238
    • Secondary endpoints: 11 to 7
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 2025 to Jan 14, 2026 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Dec 2025 to Jan 14, 2026
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the efficacy and safety of HRS-9563 in patients with mild to moderate hypertension, and to explore its appropriate dosage.
Trial Details
NCT Number NCT07297797
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Mild to Moderate Hypertension
Enrollment 238 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov